RhumbLine Advisers
AHCO icon

RhumbLine Advisers’s AdaptHealth AHCO Stock Holding History

RhumbLine Advisers’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.69M Buy
310,392
+13,033
+4% +$133K ﹤0.01% 1555
2025
Q4 		$2.96M Sell
297,359
-12,877
-4% -$123K ﹤0.01% 1666
2025
Q3 		$2.78M Buy
310,236
+10,218
+3% +$94.6K ﹤0.01% 1727
2025
Q2 		$2.83M Sell
300,018
-3,136
-1% -$27.7K ﹤0.01% 1696
2025
Q1 		$3.29M Sell
303,154
-9,956
-3% -$100K ﹤0.01% 1569
2024
Q4 		$2.98M Buy
313,110
+1,691
+0.5% +$17.1K ﹤0.01% 1681
2024
Q3 		$3.5M Buy
311,419
+40,386
+15% +$429K ﹤0.01% 1608
2024
Q2 		$2.71M Buy
271,033
+3,498
+1% +$35.5K ﹤0.01% 1721
2024
Q1 		$3.08M Buy
267,535
+2,332
+0.9% +$19.8K ﹤0.01% 1675
2023
Q4 		$1.93M Buy
265,203
+14,503
+6% +$114K ﹤0.01% 1921
2023
Q3 		$2.28M Buy
250,700
+31,061
+14% +$372K ﹤0.01% 1793
2023
Q2 		$2.67M Sell
219,639
-11,986
-5% -$134K ﹤0.01% 1744
2023
Q1 		$2.88M Buy
231,625
+10,988
+5% +$202K ﹤0.01% 1620
2022
Q4 		$4.24M Sell
220,637
-8,814
-4% -$186K 0.01% 1377
2022
Q3 		$4.31M Buy
229,451
+127,301
+125% +$2.62M 0.01% 1322
2022
Q2 		$1.84M Buy
102,150
+9,902
+11% +$161K ﹤0.01% 1803
2022
Q1 		$1.48M Sell
92,248
-9,254
-9% -$166K ﹤0.01% 1960
2021
Q4 		$2.48M Buy
101,502
+593
+0.6% +$13.9K ﹤0.01% 1761
2021
Q3 		$2.35M Sell
100,909
-3,486
-3% -$84.3K ﹤0.01% 1815
2021
Q2 		$2.86M Buy
104,395
+28,938
+38% +$825K ﹤0.01% 1765
2021
Q1 		$2.77M Buy
75,457
+49,975
+196% +$1.77M ﹤0.01% 1748
2020
Q4 		$957K Buy
25,482
+2,942
+13% +$91K ﹤0.01% 2151
2020
Q3 		$492K Buy
+22,540
New +$473K ﹤0.01% 2298

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RhumbLine Advisers's AHCO Position: Q1 2026 in Review

RhumbLine Advisers increased its AdaptHealth (AHCO) stake by 4.4% in Q1 2026, buying an estimated $133K and bringing the position to 310,392 shares worth $3.69M. The position accounts for ﹤0.01% of the portfolio, ranked #1555.

RhumbLine Advisers first reported a position in AHCO in Q3 2020 and has held it in 23 quarters since. The position peaked at $4.31M in Q3 2022. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • RhumbLine Advisers held 310,392 shares of AdaptHealth worth $3.69M as of Q1 2026.
  • RhumbLine Advisers bought 13,033 AdaptHealth shares in Q1 2026, an estimated $133K.
  • AdaptHealth made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #1555 holding.
  • RhumbLine Advisers first reported a position in AdaptHealth in Q3 2020 and has held it in 23 quarters since.
  • RhumbLine Advisers's AdaptHealth position peaked at $4.31M in Q3 2022.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.